Barely Significant
← all excerpts

Short-term efficacy of rofecoxib and diclofenac in acute shoulder pain: a placebo-controlled randomized trial.

PLoS Clin Trials · 2007 · PMC1817652 · PMID 17347681

Europe PMCDOI
1
hedged sentence
0.0250
closest p · 0.5× alpha
0.0250
boldest claim

The sentences

highly significantp = 0.025actually significant
The Kaplan-Meier estimates of the percentage of success at day 7 was 38%, 54%, 56% in placebo, diclofenac, and rofecoxib groups, respectively, with a highly significant difference between the placebo and rofecoxib groups ( p = 0.025).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.